About excelleRx
excelleRx is a Healthcare company based in Philadelphia (United States) founded in 1999, and was acquired by Enclara Pharmacia in August 2014. excelleRx has raised $37 million across 1 funding round from investors including Enclara Pharmacia, Pamlico Capital and LLR Partners. Its chief executive, as recorded, is Mark Morse. The company was acqui-hired. excelleRx offers products and services including Mail Order Medications, Retail PBM Network Services, Clinical Medication Therapy Management, and Customized Medication Packaging. Its focus areas include HealthTech, Healthcare IT, Provider and Administrative Solutions. Its competitors include Bttn, Impilo and Valify; 3 of its 3 listed competitors have raised funding.
Company details
Digital medication management tool for providers. The company has developed software that assists with medication adherence. It has features for medication access, ordering management, clinical support, and more.
- Headquarters Philadelphia, United States
- Stage Acquired
- SectorsHealthcare
- Website excellerx.com
- Acquired by Enclara Pharmacia (Aug 2014)
- Total Equity Funding$37M (USD)
in 1 rounds
- Latest Funding Round$37M (USD), Series B
Mar 2003
- InvestorsEnclara Pharmacia
& 5 more
- Acquired byEnclara Pharmacia
(Aug 2014)
Products & Services of excelleRx
excelleRx offers a comprehensive portfolio of products and services, including Mail Order Medications, Retail PBM Network Services, Clinical Medication Therapy Management, and Customized Medication Packaging.
Offers full service mail order for medications in hospice care.
Provides retail pharmacy benefit management for healthcare organizations.
Delivers consulting for medication therapy in palliative care settings.
Supplies tailored packaging for patient medications and home delivery.
Funding Insights of excelleRx
excelleRx has successfully raised a total of $37M through 1 strategic funding round. The most recent funding activity was a Series B round of $37 million completed in March 2003. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $37M
- Total Rounds 1
- Last Round Series B — $37M
- First Round $37M
(Mar 2003)
- Investors Count 4
All 1 funding rounds of excelleRx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2003 | $37M | Series B | – | – |
6 investors in total: 6 institutional.
Investors in excelleRx
excelleRx has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Enclara Pharmacia, Pamlico Capital and LLR Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pamlico Capital is engaged in private equity investments for growth companies. | pamlicocapital.com | Charlotte, United States | ||
Private equity firm investing in technology and healthcare businesses for growth capital. | llrpartners.com | |||
| wachoviacapitalpartners.com | ||||
Private equity investments are directed toward the US and Canada. | primuscapital.com | Cleveland, United States | ||
| consonancecapital.com | ||||
Pharmacy solutions for hospice care are provided through multiple channels. | 1996 | enclarapharmacia.com | Philadelphia, United States |
Investor details for excelleRx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of excelleRx
1 people are tracked at excelleRx (1 in leadership).
| Name | Role | Group |
|---|---|---|
Mark Morse | CEO | Leadership |
Complete people profiles for excelleRx
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of excelleRx
3 dated milestones of excelleRx across 15 years, from founding to its latest funding, stage changes and deals.
- Founded excelleRx is founded.
- Funding First funding round of $37.0M.
- Exit Acquired by Enclara Pharmacia.
Competitors of excelleRx
excelleRx has 3 listed competitors in our database, 3 of them funded. They include Bttn, Impilo and Valify.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bttnusa.com | 2021 | Seattle, United States | $26.5M | 24 | Digital procurement platform is utilized by healthcare professionals and buyers. | |
| impilo.health | 2020 | Philadelphia, United States | $11.5M | 23 | Integrated logistics and data solutions for digital health are provided. | |
| getvalify.com | 2014 | Frisco, United States | $3.48M | SaaS platform is used for benchmarking hospital purchased services. |
Detailed competitors of excelleRx
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of excelleRx
The website of excelleRx (excellerx.com) receives about 1.8K visits a month.
- Monthly visits1.8K
▲ 46.1% vs previous month
Websites whose visitors overlap most with excelleRx. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
enclarahealth.com | enclarahealth.com | 100% | – | ||
| deyta.com | 96% | 4.7K | #3,255,914 | View details | |
| onepointpatientcare.com | 92% | View details |
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as excelleRx (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about excelleRx
excelleRx was founded in 1999 and raised its 1st funding round 4 years after it was founded.
excelleRx is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Mark Morse is the CEO of excelleRx, as recorded in our data.
excelleRx is a funded company, having raised a total of $37M across 1 funding round to date. The company's 1st funding round was a Series B of $37M, raised on Mar 2003.
Digital medication management tool for providers. The company has developed software that assists with medication adherence. It has features for medication access, ordering management, clinical support, and more.
excelleRx offers Mail Order Medications, Retail PBM Network Services, Clinical Medication Therapy Management, and Customized Medication Packaging.
excelleRx has 6 investors. Key investors include Enclara Pharmacia, Pamlico Capital, LLR Partners, Wachovia Capital Partners, and Primus Capital.
Yes. excelleRx was acquired by Enclara Pharmacia in August 2014.